A Review of Intracoronary Abciximab in Percutaneous Coronary Interventions- where are we now and where do we go from here?
Sanjiv Sharma, Kumud Bhalla and Sarabjeet SinghAffiliation:
Chairman, Dept of Medicine, Bakersfield Heart Hospital, 2901 Sillect Ave #100, Bakersfield, CA, USA 93308.
AbstractThe rationale for intracoronary administration of abciximab is discussed. The data on use of intracoronary abciximab in percutaneous coronary interventions in acute coronary syndromes and STEMI are reviewed. Evaluation of the niche where intracoronary administration of abciximab may be useful and future research into the subject and relevant patents are discussed.
Distal embolization, intracoronary abciximab, percutaneous coronary intervention.
Purchase Online Order Reprints Order Eprints Rights and Permissions